Key Takeaways from the Healthcare Transactions Conference 2023

 

Mark Thomas, Co-founder and Director of Operations at M&A Healthcare Advisors, recently attended the Healthcare Transactions Conference hosted by the American Health Law Association in Nashville, Tennessee. Thomas shared three crucial takeaways from the event that shed light on trends and activities within the lower-middle market healthcare sector.

  1. Physician Groups: Thomas highlighted that the interest and activity in physician groups are at an all-time high, with cardiology, oncology, and gastroenterology being the primary focus areas. This surge in demand for physician practices has been witnessed in recent transactions, including M&A Healthcare Advisors’ successful sale of Medical House Calls with Compassion.
  2. Anticipated Transaction Activity: Based on Q1 data and some April figures, the majority of transactions for the remainder of 2023 are expected to consist of add-on or bolt-on acquisitions instead of platform acquisitions. Add-on and bolt-on acquisitions typically allow platforms to expand their staffing, geographic footprint, or add a service line. This trend aligns with M&A Healthcare Advisors’ findings and experiences from the past four months.
  3. Private Equity Stigma: The conference addressed the stigma surrounding private equity in healthcare, suggesting that it has a “PR problem.” Many fear that private equity firms will cut costs, reduce staff, and compromise the quality of care. However, Thomas emphasized the importance of vetting every potential buyer during a transaction process. In his experience, many private equity groups have successfully continued the legacy and quality of care established by the original operators.

In conclusion, the Healthcare Transactions Conference provided valuable insights into the current landscape of healthcare acquisitions and the role of private equity in the industry. By engaging with potential buyers and properly vetting them, healthcare business owners can ensure a smooth transaction process and maintain the quality of care they have established.

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More